Emporia, Definitive Healthcare Pact Targets Research Precision

AUSTIN, Texas – April 10, 2026 – Research recruitment firm Emporia Research today announced a significant enhancement of its healthcare targeting capabilities through a new collaboration with Definitive Healthcare, a leading provider of medical commercial intelligence. The partnership aims to provide market researchers with an unprecedented level of precision in recruiting healthcare professionals, from C-suite executives to specialized clinical staff.

By integrating Definitive Healthcare's vast repository of data, Emporia states it can now identify and engage research participants based on granular criteria that go far beyond traditional specialty or geographic filters. This move is positioned to address a critical need for higher-quality, more reliable insights in the high-stakes pharmaceutical, medtech, and healthcare services industries.

"Healthcare decision making is spread across C-suite executives, IT directors, procurement teams and clinical leaders," said Christopher Hughes, Founding Product Manager at Emporia Research, in the announcement. "Working with Definitive Healthcare gives us the ability to target these audiences with a level of specificity that hasn't existed in research recruitment before."

A New Era of Granular Insight

For years, market researchers have faced the challenge of connecting with the right individuals within the labyrinthine structure of modern healthcare organizations. Simply finding a cardiologist is no longer sufficient; researchers need to engage the specific cardiologist who has experience with a certain clinical trial, prescribes a particular class of drugs, or holds influence on a hospital's purchasing committee.

The collaboration seeks to solve this problem directly. Emporia's newly expanded targeting capabilities now include:

• Institutional Roles: Identifying specific titles like hospital executives, department heads, and IT decision-makers.
• Organizational Affiliations: Pinpointing professionals within specific health systems, ambulatory surgery centers, or group practices.
• Behavioral and Clinical Data: Targeting based on prescribing behavior, procedure volumes, and participation in clinical trials.
• Financial and Professional Credentials: Filtering by financial relationships with manufacturers and verifying licenses and board certifications.

This shift from broad-strokes recruitment to micro-targeting allows research teams to build study panels that precisely mirror the complex web of influence in healthcare. By engaging the exact individuals who shape purchasing decisions, technology adoption, and clinical policy, companies can gather more actionable and strategically relevant intelligence. This level of detail is crucial for everything from refining a new medical device's feature set to crafting a market access strategy for a breakthrough pharmaceutical.

Verification as the Cornerstone of Trust

While access to rich data is a major step forward, the partnership's emphasis on data integrity may be its most critical component. The healthcare market research industry is intensely competitive, with numerous firms offering access to large panels of healthcare professionals. However, the quality and authenticity of participants remain a persistent concern for researchers.

Emporia is leveraging its established data quality infrastructure to undergird the new targeting capabilities. This "verification stack" includes cross-referencing participants with their LinkedIn profiles, using proprietary fraud detection algorithms, and validating physicians and other clinicians against the National Provider Identifier (NPI) registry.

This multi-layered verification process is designed to ensure that every participant is precisely who they claim to be, possessing the professional background and experience required for a given study. The combination of Definitive Healthcare's industry data with Emporia's robust identity validation aims to build a foundation of trust.

"Definitive delivers highly trusted data across the healthcare industry," noted Jake Roeland, Co-Founder and CTO of Emporia Research. "Combined with our verification stack, we're giving clients confidence that they're hearing from the executives and decision makers who actually shape healthcare outcomes."

Industry analysts note that while large-scale data providers offer immense value, no database is perfect. The inherent challenge of maintaining up-to-the-minute accuracy across millions of data points means that a strong verification layer is not just a value-add, but a necessity. By pairing a powerful data source with a rigorous validation engine, the collaboration directly confronts the pervasive issue of data quality in research recruitment.

Navigating the Compliance Labyrinth

Handling such specific data about healthcare professionals inevitably raises significant privacy and compliance questions. Operating in this space requires strict adherence to regulations like the Health Insurance Portability and Accountability Act (HIPAA) in the United States and the General Data Protection Regulation (GDPR) in Europe. These frameworks govern the use of protected health information and personal data, creating a complex legal landscape for researchers.

Both companies involved in the partnership publicly state their commitment to data protection. Definitive Healthcare, which is registered as a data broker in several states, outlines its data processing and security measures in detailed privacy policies, noting that it collects information on healthcare providers primarily from public sources. Their policies also provide mechanisms for individuals to exercise their privacy rights, such as opting out of data sharing.

Similarly, Emporia Research's policies detail how respondent information is handled, emphasizing consent for participation and outlining data-sharing agreements with clients and service providers. For market researchers, this focus on compliance is non-negotiable. A failure to adhere to ethical guidelines and legal statutes not only risks severe financial penalties but can also cause irreparable damage to a brand's reputation and erode stakeholder trust.

The partnership's success will ultimately depend on its ability to deliver hyper-targeted, verified participants while meticulously navigating these ethical and regulatory waters. By providing a compliant pathway to deeper insights, the collaboration could set a new standard for how strategic intelligence is gathered across the entire healthcare ecosystem, potentially accelerating innovation and improving the effectiveness of new therapies and technologies reaching the market.